Universität zu Köln

Journal Article

Boell, Boris, Pluetschow, Annette, Buerkle, Carolin, Atta, Johannes, Pfreundschuh, Michael, Feuring-Buske, Michaela, Vogelhuber, Martin, Soekler, Martin, Eichenauer, Dennis A., Thielen, Indra, von Tresckow, Bastian, Fuchs, Michael, Engert, Andreas and Borchmann, Peter (2019). Doxorubicin, vinblastine, dacarbazine and lenalidomide for older Hodgkin lymphoma patients: final results of a German Hodgkin Study Group (GHSG) phase-I trial. Br. J. Haematol., 185 (1). S. 42 - 53. HOBOKEN: WILEY. ISSN 1365-2141

Borchmann, Peter, Eichenauer, Dennis A., Pluetschow, Annette, Haverkamp, Heinz, Kreissl, Stefanie, Fuchs, Michael, Soekler, Martin, Hellmuth, Johannes C., Meissner, Julia, Mathas, Stephan, Behringer, Karolin, Dietlein, Markus, Kobe, Carsten, Diehl, Volker and Engert, Andreas (2015). Targeted Beacopp Variants in Patients with Newly Diagnosed Advanced Stage Classical Hodgkin Lymphoma: Final Analysis of a Randomized Phase II Study. Blood, 126 (23). WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

Broeckelmann, Paul J., Goergen, Helen, Fuchs, Michael, Kriz, Jan, Semrau, Robert, Baues, Christian, Kobe, Carsten, Behringer, Karolin, Eichenauer, Dennis A., von Tresckow, Bastian, Klimm, Beate, Halbsguth, Teresa, Wongso, Diana, Pluetschow, Annette, Haverkamp, Heinz ORCID: 0000-0001-6895-4132, Dietlein, Markus, Eich, Hans T., Stein, Harald, Diehl, Volker, Borchmann, Peter and Engert, Andreas (2015). Impact of centralized diagnostic review on quality of initial staging in Hodgkin lymphoma: experience of the German Hodgkin Study Group. Br. J. Haematol., 171 (4). S. 547 - 557. HOBOKEN: WILEY. ISSN 1365-2141

Coutelle, Oliver, Buening, Hildegard, Pluetschow, Annette, Fuchs, Michael, Escalona-Espinosa, Laura, Engert, Andreas and Hacker, Ulrich ORCID: 0000-0002-3253-8206 (2014). Prognostic Serum Cytokines in Classical Hodgkin Lymphoma-Letter. Clin. Cancer Res., 20 (24). S. 6633 - 6634. PHILADELPHIA: AMER ASSOC CANCER RESEARCH. ISSN 1557-3265

Damaschin, Carla, Goergen, Helen, Kreissl, Stefanie, Pluetschow, Annette, Breywisch, Frank, Mathas, Stephan, Meissner, Julia, Soekler, Martin, Topp, Max S., Vucinic, Vladan, Zimmermann, Andreas, von Tresckow, Bastian, Fuchs, Michael, Engert, Andreas, Borchmann, Peter and Eichenauer, Dennis A. (2022). Brentuximab vedotin-containing escalated BEACOPP variants for newly diagnosed advanced-stage classical Hodgkin lymphoma: follow-up analysis of a randomized phase II study from the German Hodgkin Study Group. Leukemia, 36 (2). S. 580 - 583. LONDON: SPRINGERNATURE. ISSN 1476-5551

Eichenauer, Dennis A. ORCID: 0000-0002-1927-3514, Buehnen, Ina, Pluetschow, Annette, Kobe, Carsten, Dietlein, Markus, Wendtner, Clemens-Martin, Thorspecken, Sven, Topp, Max S., Mauser, Mareike, von Tresckow, Bastian, Fuchs, Michael, Borchmann, Peter and Engert, Andreas (2022). Phase II study of fixed-duration single-agent ibrutinib in relapsed nodular lymphocyte-predominant Hodgkin lymphoma: A report from the German Hodgkin Study Group. Hematol. Oncol., 40 (4). S. 801 - 805. HOBOKEN: WILEY. ISSN 1099-1069

Eichenauer, Dennis A., Fuchs, Michael, Pluetschow, Annette, Klimm, Beate, Halbsguth, Teresa, Boell, Boris, Von Tresckow, Bastian, Nogova, Lucia, Borchmann, Peter and Engert, Andreas (2011). Phase 2 study of rituximab in newly diagnosed stage IA nodular lymphocyte-predominant Hodgkin lymphoma: a report from the German Hodgkin Study Group. Blood, 118 (16). S. 4363 - 4366. WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

Eichenauer, Dennis A., Fuchs, Michael, Pluetschow, Annette, Klimm, Beate, Halbsguth, Teresa, Boell, Boris, von Tresckow, Bastian, Borchmann, Peter and Engert, Andreas (2011). Phase II Study of Rituximab in Newly Diagnosed Stage IA Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL): A Report From the German Hodgkin Study Group (GHSG). Blood, 118 (21). S. 1166 - 1168. WASHINGTON: AMER SOC HEMATOLOGY. ISSN 0006-4971

Eichenauer, Dennis A., Goergen, Helen, Pluetschow, Annette, Behringer, Karolin, Kreissl, Stefanie, Broeckelmann, Paul, Fuchs, Michael, Boell, Boris, von Tresckow, Bastian, Borchmann, Peter and Engert, Andreas (2015). Phase II Study of Ofatumumab in Relapsed Nodular Lymphocyte-Predominant Hodgkin Lymphoma: A Report from the German Hodgkin Study Group. Blood, 126 (23). WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

Eichenauer, Dennis A., Pluetschow, Annette, Fuchs, Michael, Behringer, Karolin, Boell, Boris, von Tresckow, Bastian, Diehl, Volker, Borchmann, Peter and Engert, Andreas (2014). Treatment of Stage IA Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL): An Analysis from the German Hodgkin Study Group (GHSG). Blood, 124 (21). WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

Eichenauer, Dennis A., Pluetschow, Annette, Fuchs, Michael, Hartmann, Sylvia, Hansmann, Martin-Leo, Boell, Boris, von Tresckow, Bastian, Borchmann, Peter and Engert, Andreas (2020). Rituximab in newly diagnosed stage IA nodular lymphocyte-predominant Hodgkin lymphoma: long-term follow-up of a phase 2 study from the German Hodgkin Study Group. Leukemia, 34 (3). S. 953 - 957. LONDON: SPRINGERNATURE. ISSN 1476-5551

Eichenauer, Dennis A., Pluetschow, Annette, Fuchs, Michael, Sasse, Stephanie, Baues, Christian, Boell, Boris, von Tresckow, Bastian, Diehl, Volker, Borchmann, Peter and Engert, Andreas (2020). Long-Term Follow-Up of Patients With Nodular Lymphocyte-Predominant Hodgkin Lymphoma Treated in the HD7 to HD15 Trials: A Report From the German Hodgkin Study Group. J. Clin. Oncol., 38 (7). S. 698 - 707. ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. ISSN 1527-7755

Eichenauer, Dennis A., Pluetschow, Annette, Fuchs, Michael, von Tresckow, Bastian, Boell, Boris, Behringer, Karolin, Diehl, Volker, Eich, Hans Theodor, Borchmann, Peter and Engert, Andreas (2015). Long-Term Course of Patients With Stage IA Nodular Lymphocyte-Predominant Hodgkin Lymphoma: A Report From the German Hodgkin Study Group. J. Clin. Oncol., 33 (26). S. 2857 - 2865. ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. ISSN 1527-7755

Eichenauer, Dennis A., Pluetschow, Annette, Kreissl, Stefanie, Soekler, Martin, Hellmuth, Johannes C. ORCID: 0000-0001-8409-3037, Meissner, Julia, Mathas, Stephan, Topp, Max S., Behringer, Karolin, Klapper, Wolfram, Kuhnert, Georg, Dietlein, Markus, Kobe, Carsten, Fuchs, Michael, Diehl, Volker, Engert, Andreas and Borchmann, Peter (2017). Incorporation of brentuximab vedotin into first-line treatment of advanced classical Hodgkin's lymphoma: final analysis of a phase 2 randomised trial by the German Hodgkin Study Group. Lancet Oncol., 18 (12). S. 1680 - 1688. NEW YORK: ELSEVIER SCIENCE INC. ISSN 1474-5488

Eichenauer, Dennis A., Pluetschow, Annette, Schroeder, Lena, Fuchs, Michael, Boell, Boris, von Tresckow, Bastian, Diehl, Volker, Borchmann, Peter and Engert, Andreas (2018). Relapsed and refractory nodular lymphocyte-predominant Hodgkin lymphoma: an analysis from the German Hodgkin Study Group. Blood, 132 (14). S. 1519 - 1526. WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

Eichenauer, Dennis A., Pluetschow, Annette, Schroeder, Lena, Fuchs, Michael, von Tresckow, Bastian, Diehl, Volker, Borchmann, Peter and Engert, Andreas (2016). Relapsed Nodular Lymphocyte-Predominant Hodgkin Lymphoma: An Analysis from the German Hodgkin Study Group (GHSG). Blood, 128 (22). WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

Gillessen, Sarah, Huettmann, Andreas, Vucinic, Vladan, Mueller, Horst, Pluetschow, Annette, Viardot, Andreas, Topp, Max S., Kobe, Carsten, Boell, Boris, Eichenauer, Dennis A. ORCID: 0000-0002-1927-3514, Sasse, Stephanie, Haverkamp, Heinz, Schmitz, Christine, Borchmann, Sven, Broeckelmann, Paul J., Heger, Jan-Michel, Fushs, Michael, Engert, Andreas, Borchmann, Peter and von Tresckow, Bastian (2022). Reinduction therapy with everolimus in combination with dexamethasone, high-dose cytarabin and cisplatinum in patients with relapsed or refractory classical Hodgkin lymphoma: an experimental phase I/II multicentre trial of the German Hodgkin Study Group (GHSG HD-R3i). Br. J. Haematol., 196 (3). S. 606 - 617. HOBOKEN: WILEY. ISSN 1365-2141

Gillessen, Sarah, Pluetschow, Annette, Vucinic, Vladan ORCID: 0000-0002-8398-285X, Ostermann, Helmut, Kobe, Carsten, Broeckelmann, Paul J., Boell, Boris, Eichenauer, Dennis A., Heger, Jan-Michel ORCID: 0000-0001-9463-8504, Borchmann, Sven, Fuchs, Michael, Borchmann, Peter, Engert, Andreas and von Tresckow, Bastian (2022). JAK inhibition with ruxolitinib in relapsed or refractory classical Hodgkin lymphoma: Final results of a phase II, open label, multicentre clinical trial (JeRiCHO). Eur. J. Haematol., 109 (6). S. 728 - 736. HOBOKEN: WILEY. ISSN 1600-0609

Hartmann, Sylvia, Eichenauer, Dennis A., Pluetschow, Annette, Mottok, Anja ORCID: 0000-0003-3125-0494, Bob, Roshanak, Koch, Karoline, Bernd, Heinz-Wolfram, Cogliatti, Sergio, Hummel, Michael, Feller, Alfred C., Ott, German, Moeller, Peter, Rosenwald, Andreas, Stein, Harald, Hansmann, Martin-Leo, Engert, Andreas and Klapper, Wolfram (2014). Histopathological features and their prognostic impact in nodular lymphocyte-predominant Hodgkin lymphoma - a matched pair analysis from the German Hodgkin Study Group (GHSG). Br. J. Haematol., 167 (2). S. 238 - 243. HOBOKEN: WILEY-BLACKWELL. ISSN 1365-2141

Hartmann, Sylvia, Eichenauer, Dennis A., Pluetschow, Annette, Mottok, Anja ORCID: 0000-0003-3125-0494, Bob, Roshanak, Koch, Karoline, Bernd, Heinz-Wolfram, Cogliatti, Sergio, Hummel, Michael, Feller, Alfred C., Ott, German, Moeller, Peter, Rosenwald, Andreas, Stein, Harald, Hansmann, Martin-Leo, Engert, Andreas and Klapper, Wolfram (2013). The prognostic impact of variant histology in nodular lymphocyte-predominant Hodgkin lymphoma: a report from the German Hodgkin Study Group (GHSG). Blood, 122 (26). S. 4246 - 4253. WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

Hartmann, Sylvia, Pluetschow, Annette, Mottok, Anja, Bernd, Heinz-Wolfram, Feller, Alfred C., Ott, German, Cogliatti, Sergio, Fend, Falko, Quintanilla-Martinez, Leticia, Stein, Harald, Klapper, Wolfram, Moeller, Peter, Rosenwald, Andreas, Engert, Andreas, Hansmann, Martin-Leo and Eichenauer, Dennis A. (2019). The time to relapse correlates with the histopathological growth pattern in nodular lymphocyte predominant Hodgkin lymphoma. Am. J. Hematol., 94 (11). S. 1208 - 1214. HOBOKEN: WILEY. ISSN 1096-8652

Jachimowicz, Ron Daniel, Pieper, Luise, Reinke, Sarah, Gontarewicz, Artur, Pluetschow, Annette, Haverkamp, Heinz, Frauenfeld, Leonie, Fend, Falko, Overkamp, Mathis, Jochims, Franziska, Thorns, Christoph, Hansmann, Martin Leo, Moller, Peter, Rosenwald, Andreas, Stein, Harald, Reinhardt, Hans Christian, Borchmann, Peter, von Tresckow, Bastian, Engert, Andreas and Klapper, Wolfram (2021). Whole-slide image analysis of the tumor as a predictor of adverse outcome in patients with advanced-stage classical Hodgkin lymphoma treated with BEACOPP. Haematologica, 106 (6). S. 1684 - 1693. PAVIA: FERRATA STORTI FOUNDATION. ISSN 0390-6078

Jacob, Anne Sophie, Kaul, Helen, Fuchs, Michael, Gillessen, Sarah, Kreissl, Stefanie, Pluetschow, Annette, Momotow, Jesko, Schaub, Valdete, Huettmann, Andreas, Haenel, Mathias, Zimmermann, Andreas, Dierlamm, Judith, Meissner, Julia, Mathas, Stephan, Martin, Sonja, Engert, Andreas, Hallek, Michael ORCID: 0000-0002-7425-4455, Borchmann, Peter and Lehmann, Clara (2022). Impact of the first COVID-19 lockdown in Germany on the rate of acute infections during intensive chemotherapy for Hodgkin lymphoma. Infection, 50 (4). S. 925 - 933. HEIDELBERG: SPRINGER HEIDELBERG. ISSN 1439-0973

Sasse, Stephanie, Broeckelmann, Paul J., Goergen, Helen, Pluetschow, Annette, Mueller, Horst, Kreissl, Stefanie, Buerkle, Carolin, Borchmann, Sven, Fuchs, Michael, Borchmann, Peter, Diehl, Volker and Engert, Andreas (2017). Long-Term Follow-Up of Contemporary Treatment in Early-Stage Hodgkin Lymphoma: Updated Analyses of the German Hodgkin Study Group HD7, HD8, HD10, and HD11 Trials. J. Clin. Oncol., 35 (18). S. 1999 - 2009. ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. ISSN 1527-7755

Sasse, Stephanie, Goergen, Helen, Pluetschow, Annette, Boell, Boris, Eichenauer, Dennis A., Fuchs, Michael, Behringer, Karolin, Zijlstra, Josee M., Greil, Richard, Markova, Jana, Topp, Max S., Meissner, Julia, Neubauer, Andreas, Baues, Christian, Engert, Andreas, Borchmann, Peter and von Tresckow, Bastian (2018). Outcome of Patients With Early-Stage Infradiaphragmatic Hodgkin Lymphoma: A Comprehensive Analysis From the German Hodgkin Study Group. J. Clin. Oncol., 36 (25). S. 2603 - 2621. ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. ISSN 1527-7755

von Tresckow, Bastian, Huettmann, Andreas, Vucinic, Vladan, Mueller, Horst, Pluetschow, Annette, Viardot, Andreas, Topp, Max S., Kobe, Carsten, Boell, Boris, Eichenauer, Dennis A., Sasse, Stephanie, Haverkamp, Heinz, Fuchs, Michael, Engert, Andreas and Borchmann, Peter (2018). Induction Therapy with Everolimus in Combination with DHAP (Dexamethasone, High-Dose AraC, Cisplatinum) in Patients with Relapsed or Refractory Classical Hodgkin Lymphoma: A Randomized, Placebo-Controlled Phase I/II Trial (HD-R3i). Blood, 132. WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

von Tresckow, Bastian, Pluetschow, Annette, Haverkamp, Heinz, Vucinic, Vladan, Rank, Andreas, Topp, Max S., Feuring-Buske, Michaela, Kobe, Carsten, Kuhnert, Georg, Boell, Boris, Eichenauer, Dennis A., Sasse, Stephanie, Fuchs, Michael, Engert, Andreas and Borchmann, Peter (2014). A Phase I Study of Everolimus in Combination with Time-Intensified DHAP ( Dexamethasone, High-Dose AraC [Cytarabine], Cisplatinum) in Patients with Relapsed or Refractory Classical Hodgkin Lymphoma (cHL). Blood, 124 (21). WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020